GS-6791

N/A

Report date: 2025/04/22 09:23:19
NME

Base Information

Drug NameGS-6791
Drug Alias NameGS-6791NX-0497
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 degraders
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsInflammationDermatitis, AtopicArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNurix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncNurix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationDermatitis, AtopicArthritis, Rheumatoid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A